2017 tables: Institutions - biological sciences - corporate

The 2017 tables are based on Nature Index data from 1 January 2016 to 31 December 2016.

Table criteria

Request a badge Export CSV
# Institution Share 2015 Share 2016 Count 2016 Change in Adjusted Share* 2015–2016
1 BGI, China 12.97 5.60 31 -55.6%
2 Biomarker Technologies Corporation, China – 0.47 2 N/A
3 Topchoice Group, China – 0.30 9 N/A
4 Yikon Genomics Co. Ltd., China 0.07 0.29 1 353.7%
5 China State Shipbuilding Corporation Limited (CSSC), China 0.16 0.27 8 80.9%
6 Gerchi Biotech Research Laboratories, China – 0.25 1 N/A
7 WuXi AppTec, China 1.17 0.25 4 -78.1%
8 Novogene Co., Ltd., China 0.22 0.24 1 13.0%
9 FiberHome Technologies Group, China 0.15 0.24 6 61.1%
10 Sinochem Group, China – 0.17 1 N/A
11 Guangzhou Darron Medscience, China – 0.16 2 N/A
12 Annoroad Gene Technology Co., Ltd., China – 0.15 1 N/A
13 PTM Biolab Co., Ltd., China – 0.15 2 N/A
14 AbMax Biotechnology Co., Ltd., China – 0.14 1 N/A
14 Cellular Biomedicine Group, Inc., China – 0.14 1 N/A
15 National Engineering Research Center for Protein Drugs, China – 0.14 1 N/A
16 China National Chemical Corporation (ChemChina), China 0.98 0.14 1 -85.6%
17 Shandong Shofine Seed Company, China – 0.14 1 N/A
18 Mabworks Biotech Co. Ltd., China – 0.13 1 N/A
19 Hangzhou Guhe Information Technology Co., Ltd., China – 0.13 1 N/A
20 Ivy Institute of Stem Cells Co. Ltd, China – 0.12 1 N/A
21 Nanjing BioSciKin Co., Ltd., China – 0.11 1 N/A
21 Alphamab Co. Ltd., China – 0.11 1 N/A
21 Shenzhen South China Pharmaceutical Co., Ltd., China – 0.11 1 N/A
22 Xiamen Amoytop Biotech Co., Ltd., China – 0.08 1 N/A
23 Kunming Biomed International (KBI), China 0.24 0.08 1 -66.3%
24 Nextomics Biosciences Co., Ltd., China – 0.07 1 N/A
25 China National Pharmaceutical Group (Sinopharm), China – 0.07 1 N/A
25 Humanwell Healthcare (Group) Co., Ltd., China – 0.07 1 N/A
26 Guangzhou Kang Rui Biological Pharmaceutical Technology Company Ltd., China 0.17 0.06 2 -61.0%
27 Xi'an Modern Chemistry Research Institute, China – 0.06 1 N/A
28 Beijing Kangpusen Biological Technology co., LTD., China – 0.06 1 N/A
29 Jiangsu Target Pharma Laboratories, Inc., China – 0.06 1 N/A
30 Jiangsu Jiangzhong Group, China 0.09 0.05 6 -38.5%
31 Beike Biotechnology, China – 0.05 1 N/A
31 Asclepius Technology Company Group Co., Ltd., China – 0.05 1 N/A
32 Shanghai Industrial μTechnology Research Institute Co., Ltd. (SITRI), China – 0.05 2 N/A
33 iCarbonX, China – 0.04 2 N/A
34 Frontier Laboratories of Systems Crop Design Co. Ltd., China – 0.04 1 N/A
35 National Chengdu Center for Safety Evaluation of Drugs, China 0.08 0.03 1 -58.9%
36 Sunshine Kaidi New Energy Group Co., Ltd., China 0.01 0.03 2 184.1%
37 Yangzhou VACBIO Bioengineering Co., Ltd., China 0.01 0.03 2 365.8%
38 Kingenta Ecological Engineering Group Co., Ltd., China – 0.03 1 N/A
38 Innovent Biologics, Inc., China – 0.03 1 N/A
38 Shanghai Zhangjiang Center for Translational Medicine, China – 0.03 1 N/A
39 Beijing Institute of Collaborative Innovation (BICI), China – 0.02 1 N/A
40 China State Institute of Pharmaceutical Industry (CSIPI), China – 0.02 1 N/A
41 Kunshan Industrial Technology Research Institute (KSITRI), China 0.09 0.01 1 -83.4%
42 Guangzhou EliteHealth Biological Pharmaceutical Technology Company Ltd., China – 0.01 1 N/A
43 Semiconductor Manufacturing International Corporation (SMIC), China – 0.01 1 N/A
44 Sinopec Corporation, China – 0.01 1 N/A
44 Yancheng Fangyuan Envirmental Protection Technology Ltd., China – 0.01 1 N/A
44 Nanjing Jiusi High-Tech Co., Ltd., China – 0.01 1 N/A
44 China National Building Materials Group Corporation (CNBM), China – 0.01 1 N/A

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals through 2022, in 2023 64 health-science journals were added to the Index. The 146 journals in the Nature Index were selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2022 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.